A detailed history of Blair William & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Blair William & CO holds 1,002,329 shares of MRK stock, worth $99.4 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,002,329
Previous 998,771 0.36%
Holding current value
$99.4 Million
Previous $124 Million 7.94%
% of portfolio
0.34%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $395,471 - $458,875
3,558 Added 0.36%
1,002,329 $114 Million
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $32.3 Million - $34.7 Million
260,742 Added 35.33%
998,771 $124 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $35,444 - $41,300
313 Added 0.04%
738,029 $97.4 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $1.51 Million - $1.65 Million
15,121 Added 2.09%
737,716 $80.4 Million
Q3 2023

Nov 09, 2023

BUY
$102.95 - $114.33 $441,449 - $490,247
4,288 Added 0.6%
722,595 $74.4 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $1.79 Million - $1.95 Million
16,435 Added 2.34%
718,307 $82.9 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $645,948 - $720,746
6,275 Added 0.9%
701,872 $74.7 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $914,709 - $1.17 Million
10,461 Added 1.53%
695,597 $77.2 Million
Q3 2022

Nov 09, 2022

BUY
$84.53 - $94.96 $3.67 Million - $4.12 Million
43,408 Added 6.76%
685,136 $59 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $203,381 - $230,543
2,436 Added 0.38%
641,728 $58.5 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $6.2 Million - $6.96 Million
-84,408 Reduced 11.66%
639,292 $52.5 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $3.06 Million - $3.84 Million
42,370 Added 6.22%
723,700 $55.5 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $3.94 Million - $4.34 Million
55,013 Added 8.78%
681,330 $51.2 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $703,451 - $778,088
-10,005 Reduced 1.57%
626,317 $48.7 Million
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $2.1 Million - $2.47 Million
-30,458 Reduced 4.57%
636,322 $49.1 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $5.73 Million - $6.35 Million
79,779 Added 13.59%
666,780 $54.5 Million
Q3 2020

Nov 06, 2020

BUY
$73.18 - $82.95 $5.68 Million - $6.44 Million
77,638 Added 15.24%
587,001 $48.7 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $1.4 Million - $1.6 Million
19,932 Added 4.07%
509,363 $39.4 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $2.85 Million - $3.94 Million
-44,905 Reduced 8.4%
489,431 $37.7 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $1.31 Million - $1.48 Million
-16,871 Reduced 3.06%
534,336 $48.6 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $2.13 Million - $2.32 Million
27,973 Added 5.35%
551,207 $46.4 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $3.2 Million - $3.73 Million
45,755 Added 9.58%
523,234 $43.9 Million
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $3.63 Million - $4.14 Million
52,106 Added 12.25%
477,479 $39.7 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $963,138 - $1.12 Million
14,763 Added 3.6%
425,373 $32.5 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $148,782 - $174,959
2,579 Added 0.63%
410,610 $29.1 Million
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $65,875 - $77,397
-1,296 Reduced 0.32%
408,031 $24.8 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $1.09 Million - $1.27 Million
-21,474 Reduced 4.98%
409,327 $22.3 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $61,221 - $73,105
1,186 Added 0.28%
430,801 $24.2 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $25.2 Million - $27.1 Million
429,615
429,615 $27.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.